Research and Markets: Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/m2mjmr/human_embryonic_st) has announced the addition of the "Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report" report to their offering.

“Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report”

This report analyzes the worldwide markets for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2018.

The report profiles 26 companies including many key and niche players. Companies mentioned include:

- Advanced Cell Technology Inc.

- BioTime Inc.

- Cellartis AB

- Molecular Transfer Inc.

- PerkinElmer Inc.

- Pfizer Inc.

- Stem Cell Network

- ViaCyte Inc.,

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Industry Overview

2. Market Dynamics

3. Regulatory Landscape

4. Hesc Application Areas

5. Competition

6. Product Introductions/Launches

7. Recent Industry Activity

8. Focus On Select Global Players

9. Global Market Perspective

III. MARKET

1. The United States

2. Europe

3. Rest Of World

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 26 (including Divisions/Subsidiaries - 31)

The United States (24)

Canada (1)

Europe (4)

- The United Kingdom (1)

- Rest of Europe (3)

Asia-Pacific (Excluding Japan) (1)

Middle-East (1)

For more information visit http://www.researchandmarkets.com/research/m2mjmr/human_embryonic_st.